“Our commitment to quality and experience allow us a head start of 6 to 8 months in access to innovative clinical trials” Published on 25/10/2024 We received a visit from Dr. Jordi Rodón, head of the Early Stage Drug Development Unit at MD Anderson Houston. Rodón specialises in early drug development, biomarker discovery, personalised cancer medicine and neuro-oncology.
The potential of a protein called L1CAM as one of the most promising treatment targets in cancer Published on 17/01/2020 The results have recently been published of a study that promise to change the way we deal with cancer.
How to survive a presidential session of ESMO (and speak to over 6,000 people) Published on 08/10/2019 I was just about to leave for my summer holiday. In fact, I was at the airport with my wife and daughter when the phone rang. I already knew the call would come, and I was awaiting it with anxiety/fear and excitement in equal measures.